House Bill 229

Actions
Last Action 01/10/24: to Committee on Committees (H)
Title AN ACT relating to gene therapy.
Bill Documents Introduced
Bill Request Number 21
Sponsors E. Callaway, J. Decker, D. Bentley, J. Hodgson, M. Proctor, S. Rawlings
Summary of Original Version Create a new section of KRS 217.005 to 217.215, the Kentucky Food, Drug, and Cosmetic Act, to define terms; require products that are known to be or could act as gene therapy to be labeled with the words "Potential Gene Therapy Product" or "Gene Therapy Product"; require any entity in the state that produces, sells, or distributes a product in this state with the capacity to infect an individual with a disease or to expose an individual with genetically modified material to provide information upon request on how individuals may be exposed; require informed consent before any entity makes available a product in this state that would act as a medical intervention, vaccine, drug, or genetic modification.
Index Headings of Original Version Diseases - Gene therapy or genetic change, label and informed consent, requirements
Drugs and Medicines - Gene therapy or genetic change, label and informed consent, requirements
Foods - Gene therapy or genetic change, label and informed consent, requirements
Hazardous Materials - Gene therapy or genetic change, label and informed consent, requirements
Public Health - Gene therapy or genetic change, label and informed consent, requirements

Actions

Top
01/10/24
  • introduced in House
  • to Committee on Committees (H)


Last updated: 4/13/2024 6:10 PM (EDT)